HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 182 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,576,816 | +1.3% | 719,376 | +8.8% | 0.00% | 0.0% |
| Q2 2023 | $23,271,369 | +24.3% | 661,306 | +15.3% | 0.00% | +50.0% |
| Q1 2023 | $18,728,867 | +61674.7% | 573,625 | +4.2% | 0.00% | -50.0% |
| Q4 2022 | $30,318 | -99.9% | 550,241 | +3.8% | 0.00% | 0.0% |
| Q3 2022 | $23,486,000 | +2.7% | 530,284 | +13.1% | 0.00% | +33.3% |
| Q2 2022 | $22,864,000 | +6.4% | 468,819 | +6.2% | 0.00% | 0.0% |
| Q1 2022 | $21,484,000 | +18.6% | 441,614 | +4.0% | 0.00% | +50.0% |
| Q4 2021 | $18,114,000 | +15.0% | 424,828 | +3.3% | 0.00% | 0.0% |
| Q3 2021 | $15,757,000 | +148.1% | 411,110 | +82.8% | 0.00% | +100.0% |
| Q2 2021 | $6,350,000 | +90.7% | 224,942 | +123.3% | 0.00% | 0.0% |
| Q1 2021 | $3,329,000 | +0.8% | 100,757 | +10.2% | 0.00% | 0.0% |
| Q4 2020 | $3,304,000 | +109.6% | 91,400 | +96.6% | 0.00% | – |
| Q3 2020 | $1,576,000 | – | 46,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |